— Know what they know.
Not Investment Advice

BRSF OTC

Brain Scientific Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +500.0% 1Y: -99.9% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 50 · $746 mcap · 878010 float · 0.0002% daily turnover · Short 100% of daily vol

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 13 Grade D
Profitability
20
Balance Sheet
30
Earnings Quality
42
Growth
17
Value
34
Momentum
23
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BRSF scores highest in Earnings Quality (42/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-6.81
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✓ ✗ ✓ ✗ ✗
Beneish M-Score
-6.87
Unlikely Manipulator
Ohlson O-Score
1.17
Bankruptcy prob: 76.2%
High Risk
Credit Rating
CCC
Score: 16.3/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.52x
Accruals: -44.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BRSF scores -6.81, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BRSF scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BRSF's score of -6.87 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BRSF's implied 76.2% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BRSF receives an estimated rating of CCC (score: 16.3/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
0.00x
P/S
0.00x
P/B
0.00x
P/FCF
-0.02x
P/OCF
—
EV/EBITDA
-0.34x
EV/Revenue
10.44x
EV/EBIT
-0.30x
EV/FCF
-0.38x
Earnings Yield
-9239.54%
FCF Yield
-4803.07%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. BRSF currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.930
NI / EBT
×
Interest Burden
1.665
EBT / EBIT
×
EBIT Margin
-34.562
EBIT / Rev
×
Asset Turnover
0.017
Rev / Assets
×
Equity Multiplier
6.935
Assets / Equity
=
ROE
-633.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BRSF's ROE of -633.9% is driven by financial leverage (equity multiplier: 6.93x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 0.93 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1447 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
1211.2%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
11
-60.7% YoY
Revenue / Employee
$19,506
Rev: $214,564
Profit / Employee
$-1,122,169
NI: $-12,343,858
SGA / Employee
$850,984
Avg labor cost proxy
R&D / Employee
$27,446
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
ROE 8.4% 28.0% 54.6% 13.1% 2.1% -8.0% -41.0% -6.3% -6.34%
ROA -3.3% -8.5% -25.1% -68.0% -1.7% -1.3% -1.8% -91.4% -91.41%
ROIC 10.3% 39.4% 85.8% -74.6% -87.2% -1.2% -1.4% -94.8% -94.76%
ROCE 9.1% 28.1% 53.5% -95.8% -1.2% -1.1% -1.7% -1.7% -1.71%
Gross Margin 61.0% 59.6% 21.5% 30.5% 33.2% 1.3% 64.5% -1.3% -1.27%
Operating Margin -479.7% -137.8% -328.4% -20.5% -11.9% -57.0% -351.5% 76.6% 76.62%
Net Margin -443.4% -144.9% -341.4% -22.0% -13.5% -31.7% -363.2% -777.1% -777.15%
EBITDA Margin -479.6% -137.8% -326.6% -19.7% -10.7% -18.2% -357.4% -20.3% -20.31%
FCF Margin -469.9% -175.9% -195.4% -22.3% -15.9% -16.7% -17.0% -27.8% -27.82%
OCF Margin -456.2% -172.8% -192.8% -22.1% -15.8% -16.6% -16.9% -27.7% -27.66%
ROIC Economic snapshot only -84.94%
Cash ROA snapshot only -50.54%
Cash ROIC snapshot only -92.26%
CROIC snapshot only -92.78%
NOPAT Margin snapshot only -28.41%
Pretax Margin snapshot only -57.53%
R&D / Revenue snapshot only 1.41%
SGA / Revenue snapshot only 43.63%
SBC / Revenue snapshot only 1.66%
Valuation
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
P/E Ratio -95.31 -9.45 -4.21 -63.31 -1.22 -0.97 -0.94 -0.01 -0.000
P/S Ratio 42261.60 1821.23 1039.11 2168.13 30.41 22.85 26.54 0.58 0.003
P/B Ratio -8.01 -2.65 -2.30 -829.11 -5.18 1.15 1.70 0.03 0.000
P/FCF -89.94 -10.35 -5.32 -97.24 -1.91 -1.37 -1.56 -0.02 -0.021
P/OCF — — — — — — — — —
EV/EBITDA -91.44 -11.02 -5.26 -69.37 -2.57 -0.93 -1.07 -0.34 -0.340
EV/Revenue 43853.18 2122.00 1268.44 2205.25 57.31 18.62 26.64 10.44 10.440
EV/EBIT -91.42 -11.02 -5.24 -67.71 -2.47 -0.87 -1.00 -0.30 -0.302
EV/FCF -93.33 -12.06 -6.49 -98.90 -3.61 -1.12 -1.57 -0.38 -0.375
Earnings Yield -1.0% -10.6% -23.8% -1.6% -82.3% -1.0% -1.1% -92.4% -92.40%
FCF Yield -1.1% -9.7% -18.8% -1.0% -52.2% -73.0% -63.9% -48.0% -48.03%
PEG Ratio snapshot only 0.000
EV/Gross Profit snapshot only 41.234
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Current Ratio 0.02 0.03 0.02 0.26 0.15 0.59 0.36 0.18 0.176
Quick Ratio 0.02 0.03 0.02 0.23 0.11 0.57 0.34 0.16 0.156
Debt/Equity -0.31 -0.45 -0.51 -15.33 -4.72 0.18 0.29 0.66 0.663
Net Debt/Equity — — — — — -0.21 0.01 0.49 0.490
Debt/Assets 12.36 13.68 23.52 0.80 0.93 0.10 0.15 0.24 0.244
Debt/EBITDA -3.45 -1.61 -0.96 -1.26 -1.24 -0.18 -0.18 -0.43 -0.434
Net Debt/EBITDA -3.32 -1.56 -0.95 -1.17 -1.21 0.21 -0.00 -0.32 -0.321
Interest Coverage -12.04 -15.52 -19.20 -15.52 -12.78 -4.16 -4.13 -2.06 -2.057
Equity Multiplier -0.03 -0.03 -0.02 -19.25 -5.08 1.74 1.95 2.72 2.720
Cash Ratio snapshot only 0.101
Debt Service Coverage snapshot only -1.828
Cash to Debt snapshot only 0.261
FCF to Debt snapshot only -2.084
Defensive Interval snapshot only 28.3 days
Efficiency & Turnover
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Asset Turnover 0.01 0.04 0.10 0.02 0.07 0.06 0.07 0.02 0.017
Inventory Turnover 0.32 2.04 4.32 1.25 3.66 4.88 5.05 1.08 1.084
Receivables Turnover -0.04 0.29 0.94 15.70 -41.64 23.87 43.22 24.02 24.015
Payables Turnover 0.00 0.00 0.00 0.17 0.26 0.24 0.24 0.15 0.147
DSO -10006 1275 387 23 -9 15 8 15 15.2 days
DIO 1151 179 84 292 100 75 72 337 336.7 days
DPO 705172 138762 74449 2202 1393 1495 1548 2479 2478.9 days
Cash Conversion Cycle -714026 -137308 -73978 -1886 -1302 -1404 -1467 -2127 -2127.0 days
Fixed Asset Turnover snapshot only 1.024
Operating Cycle snapshot only 351.9 days
Cash Velocity snapshot only 0.287
Capital Intensity snapshot only 54.733
Growth (YoY)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Revenue — — — — 286.4% 48.4% 30.8% -19.3% -19.26%
Net Income — — — — -15.2% -5.0% -2.7% -26.2% -26.16%
EPS — — — — -15.2% -4.0% -75.2% -30.1% -30.15%
FCF — — — — -8.7% -3.7% -1.8% -0.7% -0.72%
EBITDA — — — — -12.4% -4.1% -2.3% 22.0% 21.98%
Op. Income — — — — -12.9% -5.2% -2.8% 10.9% 10.86%
OCF Growth snapshot only -1.16%
Asset Growth snapshot only -12.20%
Debt Growth snapshot only -73.12%
Shares Change snapshot only -95.95%
Growth Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Revenue Stability — — — — — — — — —
Earnings Stability — — — — — — — — —
Margin Stability — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — —
Earnings Smoothness — — — — — — — — —
ROE Trend — — — — — — — — —
Gross Margin Trend — — — — — — — — —
FCF Margin Trend — — — — — — — — —
Sustainable Growth Rate — — — — — — — — —
Internal Growth Rate — — — — — — — — —
Cash Flow Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
OCF/Net Income 1.03 0.90 0.78 0.64 0.63 0.70 0.59 0.52 0.517
FCF/OCF 1.03 1.02 1.01 1.01 1.01 1.00 1.01 1.01 1.006
FCF/Net Income snapshot only 0.520
CapEx/Revenue 13.6% 3.1% 2.6% 22.1% 10.6% 8.2% 10.4% 15.5% 15.52%
CapEx/Depreciation snapshot only 0.041
Accruals Ratio 0.10 -0.88 -5.51 -0.24 -0.61 -0.40 -0.75 -0.44 -0.442
Sloan Accruals snapshot only -0.295
Cash Flow Adequacy snapshot only -178.268
Dividends & Buybacks
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — —
FCF Payout Ratio — — — — — — — — —
Total Payout Ratio — — — — — — — — —
Div. Increase Streak — — — — — — — — —
Chowder Number — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% -0.2% -0.2% -0.1% -2.4% -2.7% -2.3% 0.0% 0.00%
Total Shareholder Return 0.0% -0.2% -0.2% -0.1% -2.4% -2.7% -2.3% 0.0% 0.00%
DuPont Factors
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 0.89 0.89 0.93 0.930
Interest Burden (EBT/EBIT) 0.92 1.00 1.02 1.05 1.08 1.24 1.20 1.66 1.665
EBIT Margin -479.70 -192.56 -242.05 -32.57 -23.24 -21.31 -26.57 -34.56 -34.562
Asset Turnover 0.01 0.04 0.10 0.02 0.07 0.06 0.07 0.02 0.017
Equity Multiplier -0.03 -0.03 -0.02 -19.25 -1.25 5.96 22.25 6.93 6.935
Per Share
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
EPS (Diluted TTM) $-1.10 $-2.98 $-6.01 $-0.30 $-17.83 $-14.89 $-10.53 $-9.24 $-9.24
Book Value/Share $-13.09 $-10.63 $-11.01 $-0.02 $-4.18 $12.51 $5.80 $3.47 $4.53
Tangible Book/Share $-13.09 $-10.63 $-11.01 $-0.41 $-23.76 $-3.41 $-3.28 $-4.69 $-4.69
Revenue/Share $0.00 $0.02 $0.02 $0.01 $0.71 $0.63 $0.37 $0.17 $0.23
FCF/Share $-1.16 $-2.72 $-4.76 $-0.19 $-11.32 $-10.55 $-6.30 $-4.80 $-6.26
OCF/Share $-1.13 $-2.67 $-4.69 $-0.19 $-11.24 $-10.50 $-6.26 $-4.78 $-6.23
Cash/Share $0.16 $0.14 $0.04 $0.03 $0.58 $4.93 $1.64 $0.60 $0.78
EBITDA/Share $-1.19 $-2.98 $-5.87 $-0.28 $-15.88 $-12.63 $-9.23 $-5.30 $-5.30
Debt/Share $4.11 $4.80 $5.63 $0.35 $19.75 $2.25 $1.68 $2.30 $2.30
Net Debt/Share $3.95 $4.65 $5.58 $0.32 $19.17 $-2.68 $0.04 $1.70 $1.70
Per Employee
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Employee Count snapshot only 11
Revenue/Employee snapshot only $19505.82
Income/Employee snapshot only $-1043744.64
EBITDA/Employee snapshot only $-599177.91
FCF/Employee snapshot only $-542578.45
Assets/Employee snapshot only $1067602.27
Market Cap/Employee snapshot only $11296.50
Academic Models
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Altman Z-Score — — — — — — — — -6.807
Altman Z-Prime snapshot only -17.251
Piotroski F-Score 1 2 2 2 6 5 5 3 3
Beneish M-Score — — — — 91.70 21.91 -5.57 -6.87 -6.868
Ohlson O-Score snapshot only 1.166
Net-Net WC snapshot only $-4.92
EVA snapshot only $-6738931.40
Credit
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Credit Rating snapshot only CCC
Credit Score 12.65 12.77 12.76 20.00 13.01 19.23 17.53 16.31 16.306
Credit Grade snapshot only 17
Credit Trend snapshot only -3.694
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 6
Sector Credit Rank snapshot only 7

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms